TL;DR
This paper introduces a novel "molecularly cleavable bioink" strategy for digital light processing (DLP) bioprinting. By combining a printable component (GelMA) with a degradable component (HAMA), they achieve high-fidelity printing of complex soft tissues. Post-printing enzymatic digestion of HAMA then allows precise tuning of mechanical properties to match various target tissues, from muscle to brain, while enhancing cell function.
What Problem Does This Paper Address?
3D bioprinting, particularly using DLP, excels at creating intricate structures. However, fabricating functional soft tissues has been a major hurdle. The challenge lies in balancing two conflicting requirements: bioinks need to be mechanically robust enough for high-resolution printing (especially in DLP's bottom-up approach), but also soft and conducive to cell survival and function. Stiff bioinks hinder cell activity, while soft bioinks often lack the structural integrity for precise printing, leading to a trade-off between fidelity and biocompatibility. This paper aims to bridge this gap by developing a bioink system that allows for both high-fidelity printing and tunable mechanical properties suitable for diverse soft tissues.
Methods
The core innovation is the development of a molecularly cleavable bioink system based on gelatin methacryloyl (GelMA) and hyaluronic acid methacrylate (HAMA).
- Bioink Formulation: GelMA provides the photocrosslinkable network for printing, while HAMA is added to enhance the mechanical strength and printability of the bioink, allowing for higher resolution and more complex structures than GelMA alone.
- DLP Bioprinting: A custom-built DLP bioprinter was used to fabricate 3D constructs layer-by-layer using UV light. The process was optimized with a photoabsorber (Ponceau 4R) to control curing depth and resolution.
- Enzymatic Digestion: After printing, the HAMA component within the GelMA/HAMA constructs is selectively degraded using the enzyme hyaluronidase (Hase). This enzymatic digestion breaks down the HAMA chains, reducing the overall crosslinking density and thus the stiffness of the hydrogel.
- Mechanical Tuning: By varying the concentration of HAMA in the initial bioink and controlling the concentration and duration of Hase digestion, the authors demonstrate precise tuning of the final construct's compressive modulus across a wide range (from ~1 kPa to over 100 kPa).
- Mathematical Modeling: A quadratic polynomial model was developed to predict the mechanical properties of the digested constructs based on bioink formulation and digestion parameters, allowing for rational design of tissue-mimics.
- Cellular and Tissue Studies: The authors evaluated the impact of this approach on various cell types (NIH/3T3 fibroblasts, C2C12 myoblasts, HepG2/C3A liver cells, and neural progenitor cells) and demonstrated the fabrication of functional tissue-mimics for muscle, liver, and brain.
Datasets
Not discussed in the paper. The study focuses on experimental validation and mathematical modeling of their bioink system.
Key Insights and Ideas
- The "Printability vs. Biocompatibility" Dilemma Solved: The most significant insight is the elegant solution to the long-standing trade-off in soft tissue bioprinting. By making a component of the bioink cleavable, they can achieve high printability initially and then soften the material to create a more biologically relevant microenvironment.
- HAMA as a "Printability Enhancer": HAMA, while not ideal for cell function in its crosslinked state, acts as a crucial additive to improve the mechanical properties of GelMA bioinks, enabling high-fidelity DLP printing of complex shapes that would otherwise be impossible.
- Enzymatic Digestion as a Precise "Mechanical Tuner": The ability to precisely control the mechanical properties of the final construct by adjusting enzyme concentration and incubation time is a powerful tool for mimicking the diverse stiffness of native tissues.
- Bio-inspired Microenvironments: The degradation of HAMA not only softens the matrix but also likely creates more space and porosity, which can enhance cell spreading, migration, and differentiation.
- A Versatile Platform: The demonstrated success across multiple tissue types (muscle, liver, brain) highlights the broad applicability of this molecularly cleavable bioink strategy.
Key Results
- High-Fidelity Printing: The GelMA/HAMA bioinks enabled the printing of complex 3D structures, including pyramids, gyroids, and intricate channel networks, with resolutions down to 200 µm.
- Tunable Mechanical Properties: The compressive modulus of the printed constructs could be precisely tuned from approximately 1 kPa to over 180 kPa by controlling Hase digestion.
- Tissue Mimicry: The authors successfully fabricated constructs with mechanical properties matching those of the brain (1-4 kPa), liver (1-10 kPa), lung (10-15 kPa), and heart (30-60 kPa).
- Enhanced Cell Function:
- Muscle: C2C12 myoblasts in digested constructs showed improved fusion and myotube formation compared to undigested controls.
- Liver: HepG2/C3A cells exhibited higher viability, metabolic activity, and secretion of albumin and urea in digested constructs, indicating improved liver function.
- Brain: Neural progenitor cells (SNaPs) in digested constructs showed enhanced proliferation, viability, and differentiation into neurons and astrocytes. These neurons also exhibited functional electrophysiological activity, including synchronized network bursts, on a multi-electrode array (MEA).
- Mathematical Model Validation: The developed mathematical model accurately predicted the mechanical properties of the digested constructs, with an R² value of 0.9590.
Limitations and Future Work
- Cell Viability During Digestion: While generally well-tolerated, the authors note that high enzyme concentrations and long treatment times could negatively impact cell survival. Careful optimization of digestion parameters is crucial.
- Leaching of Cells: Some cell leaching was observed during HAMA digestion, although it did not significantly impair overall cell viability or metabolic activity.
- Alternative Cleavable Components: The paper briefly mentions the possibility of cleaving GelMA itself (using collagenase) as an alternative strategy, suggesting further exploration of different cleavable bioink components.
- Broader Tissue Applications: The authors suggest that this platform could be extended to a wider range of soft and ultrasoft tissues.
- In Vivo Translation: While promising for tissue engineering and modeling, further studies would be needed to assess the long-term behavior and integration of these bioprinted constructs in vivo.
Summary updated